American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead Story: Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition

Lead Story: Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition

Tuesday 27th December 2022

Learn about NIAAA's new definition of recovery from alcohol use disorder and other key studies in addiction medicine on 'Addiction Medicine Unpacked'.
8 minutes
Informative
Educational
Eye-opening
Thought-provoking
Engaging

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Redefining Recovery: NIAAA's New Approach to Alcohol Use Disorder

By adopting a uniform definition, researchers and health care professionals can more precisely operationalize and measure recovery-related processes.
How do we define recovery from alcohol use disorder (AUD)? This episode of 'Addiction Medicine Unpacked' from ASAM tackles this crucial question by diving into the National Institute on Alcohol Abuse and Alcoholism's (NIAAA) latest research. Hosted by Claire Rasmussen, the episode unpacks the newly developed NIAAA definition, which frames recovery as both a process and an outcome. It highlights two key components: remission from DSM-5 AUD and cessation from heavy drinking, even if it's not complete abstinence.
The discussion also emphasizes the importance of biopsychosocial functioning and quality of life in enhancing recovery outcomes. This uniform definition aims to help researchers and healthcare professionals measure recovery-related processes more precisely. But that's not all. The episode also covers a range of other studies, including the use of benzodiazepine-sparing alcohol withdrawal protocols, the long-term effects of cannabis on cognitive function, and the alarming rise in polysubstance overdose deaths during the fentanyl era.
You'll also hear about innovative concepts like 'pre-addiction' for early intervention and the association between cannabis potency and mental health issues. The episode doesn't stop there; it offers insights into the effectiveness of buprenorphine and naltrexone in treating opioid use disorder, especially when combined with polysubstance use. There's also a deep dive into the risks associated with opioid dose tapering and the use of buprenorphine treatment in jails.
This episode is a treasure trove of information for anyone interested in the latest developments in addiction medicine, blending scientific research with practical applications to improve lives.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.